Insider Cluster (1 insider) ·Filed Feb 23, 2026
Insider cluster: 2 insiders, $29K total
Actionable Insight • Neutral
No material insider buying or selling detected; this grant is part of standard executive compensation and not a trading signal.
Final — all horizons settled through T+60d
OVID ▲ +66.21% at T+60d
NEUTRAL call +66.21% · α vs SPY +57.95% · entry $1.45 → $2.41
T+1d
+4.14%
call +4.14% · α +3.40%
$1.51
settled 8mo ago
T+5d
+14.48%
call +14.48% · α +13.86%
$1.66
settled 8mo ago
T+20d
+75.86%
call +75.86% · α +79.81%
$2.55
settled 7mo ago
T+60d
+66.21%
call +66.21% · α +57.95%
$2.41
settled 5mo ago
Price Chart
Loading chart...
Executive Summary
Ovid Therapeutics' Chief Business and Financial Officer, Rona Jeffrey A, was granted 68,125 shares as a non-cash award. This is a routine compensation event with no open-market transaction or cash involvement.
Key Financial Metrics
Direction
mixed
Total Value
$0.00
Insiders
1
Key Facts
- Rona Jeffrey A (CBFO) granted 68,125 shares on 2026-02-26
- Transaction was non-cash (Form 4 code 'A'), valued at $0 in economic terms
- No open-market purchase or sale activity in the last 7 days
Financial Impact
Non-cash award of 68,125 shares; no direct financial impact
shares outstandingequity compensation
Risk Factors
- Potential future dilution from share grant, though magnitude is small relative to market cap
Market Snapshot
Exchange
Nasdaq
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (1 trades, 7d window) | cluster-OVID-1772487081641 |
11 reports for OVID
Track record builds as more directional reports settle.
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 14, 2026 10w ago | 144 | $2.89 | awaiting T+60 | — | $2.26 (−21.80%) |
Jul 8, 2026 15w ago | 8-K | $2.73 $2.49 | ▼ −8.79% | ▼ −11.10% | $2.26 (−17.22%) |
Jun 3, 2026 20w ago | 8-K | $2.39 $2.93 | ▲ +22.59% | ▲ +20.10% | $2.26 (−5.44%) |
May 12, 2026 24w ago | Press Release | $2.87 $2.65 | ▼ −7.67% | ▼ −12.05% | $2.26 (−21.25%) |
Apr 27, 2026 26w ago | EFFECT | $2.69 $2.38 | ▼ −11.52% | ▼ −16.30% | $2.26 (−15.99%) |
Apr 21, 2026 27w ago | S-3 | $2.66 $2.44 | ▼ −8.27% | ▼ −13.05% | $2.26 (−15.04%) |
Apr 20, 2026 27w ago | 8-K | $2.89 $2.49 | ▼ −13.84% | ▼ −20.62% | $2.26 (−21.80%) |
Mar 18, 2026 31w ago | 8-K | $2.30 $2.21 | ▼ −3.91% | ▼ −15.44% | $2.26 (−1.74%) |
Mar 18, 2026 31w ago | Press Release | $2.30 $2.21 | ▼ −3.91% | ▼ −15.44% | $2.26 (−1.74%) |
Mar 18, 2026 31w ago | Press Release | $2.30 $2.21 | ▼ −3.91% | ▼ −15.44% | $2.26 (−1.74%) |
Showing 10 of 11
US Market Status
Market Closed — Opens Wed (< 1m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers